Effects of anti-inflammatory dietary patterns on non-alcoholic fatty liver disease: a systematic literature review

Eur J Nutr. 2023 Jun;62(4):1563-1578. doi: 10.1007/s00394-023-03085-0. Epub 2023 Jan 24.

Abstract

Purpose: Non-alcoholic fatty liver disease (NAFLD) is the leading chronic hepatic condition. Low-grade chronic inflammation contributes to disease progression. Diet has protective effects on hepatic health and inflammatory pathways. The purpose of this review is to systematically review and describe the effects of anti-inflammatory dietary patterns on NAFLD.

Methods: The Cochrane CENTRAL Library, Cumulative Index of Nursing and Allied Health Literature, Embase, MEDLINE and Web of Science databases were searched. A total of 252 records were identified, 7 of which were included in this review. The revised Cochrane risk-of-bias tool was used to conduct a quality assessment for randomised trials. Certainty of evidence was assessed using the grading of recommendations, assessment, development, and evaluation tool.

Results: Of the 7 included studies, 6 were classified as low risk of bias and studies ranged from high to very low certainty of evidence. In the randomised-controlled studies systematically reviewed, either adherence to the Mediterranean, DASH, or FLiO diet was studied, against usual care or energy matched controls, with a total of 255 participants. Anti-inflammatory dietary pattern adherence significantly reduced the severity of most hepatic and inflammatory markers, and secondary outcomes. A minority of outcomes were improved significantly more than controls.

Conclusion: Anti-inflammatory dietary patterns showed benefits to NAFLD risk factors, severity markers and inflammatory markers compared to the control diet. It is unclear whether reductions in the evaluated parameters are related solely to the anti-inflammatory diet or weight loss resulting from caloric restriction, as improvements in control groups were also evidenced. Current limited body of evidence indicates need for further research including isocaloric dietary patterns, longer interventions, measures of inflammatory markers, and studies including normal-weight subjects to confirm findings at higher certainty.

Prospero registration: CRD42021269382.

Keywords: Fatty liver; Hepatic steatosis; Inflammation; Mediterranean diet; NAFLD.

Publication types

  • Systematic Review
  • Review

MeSH terms

  • Anti-Inflammatory Agents
  • Chronic Disease
  • Diet
  • Disease Progression
  • Humans
  • Non-alcoholic Fatty Liver Disease* / prevention & control

Substances

  • Anti-Inflammatory Agents